Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
- C4325 BAY-678Summary: HNE inhibitor
- C4437 UCF 101Summary: inhibitor of the proteolytic activity of Omi/HtrA2
- C4501 cis-ACCPSummary: type IV collagen-specific MMP-2 and MMP-9 inhibitor
- C4787 EquisetinSummary: HIV-1 integrase inhibitor
- C5038 2-cyano-PyrimidineSummary: cathepsin K inhibitor
- B7854 o-PhenanthrolineSummary: metalloprotease inhibitor
- C5347 Calpain Inhibitor XIISummary: reversible and selective inhibitor of calpain I
- C5839 Tosyllysine Chloromethyl Ketone (hydrochloride)Summary: serine proteinases inhibitor
- C5589 ChymostatinSummary: chymotryptase-like serine proteases inhibitor
- C5598 MMP-2/MMP-9 Inhibitor ISummary: potent inhibitor of matrix metalloproteinase-2 (MMP-2) and MMP-9